Blockchain-
enabled Open Science

Jerome Hamilton

Jerome Hamilton, CEO of Open Therapeutics, leads the company's scale and global expansion, as well as manages business development, sales, marketing, and investor relations. He joined Open TherapeuticsTM after serving as Stratasys’ Senior Vice President of Global Operations, before which he was Vice President of LEAN Six Sigma Operations, Corporate Quality and Acquisition Integration for 3M. There, he played a major role in devising strategy and operational plans for the company’s largest business group, Industrial Business Group. He also led the company’s Masking and Surface Protection Business with full P&L responsibility.

Hamilton received his Bachelor of General Science from Morehouse College, his Bachelor of Science in Industrial Engineering from Georgia Tech, Master of Science in Engineering Management from University of Detroit, Mercy; and Master of Science for International Logistics from Georgia Tech; he is a graduate of the Advanced Management Program, Harvard Business School.

Hamilton is Chairman of the Board for Goodwill Easter Seals Minnesota, Real Life 101 Board member, and V2SOFT Board Member. He was listed in the 2014 Savoy Magazine list of Most Influential Blacks in Corporate America and was recognized as one of the Top 50 diversity professionals in industry– Global Diversity List, supported by The Economist, (globaldiversitylist.com).

In the coming months Open TherapeuticsTM will provide to global researchers, a crowdsourcing web platform that will host freely available open pharma and medical technologies framework, created by Jason Barkeloo and his team, to global researchers. Scientists can freely adopt the open technologies and develop manuscripts on the science they conduct around the technologies.

Dave Knox

As a brand marketer, venture investor, and startup advisor, Dave Knox bridges the worlds of the Fortune 500 and entrepreneurship. The intersection of these two worlds is the subject of his book, Predicting The Turn: The High Stakes Game of Business Between Startups and Blue Chips, which was named the Grand Prix winner of the 2017 Atticus Award. Dave is the former Chief Marketing Officer for Rockfish, a widely recognized digital innovation agency that was acquired by WPP, where he also served as the Managing Director for WPP Ventures. Prior to Rockfish, Knox was a seven-year veteran of Procter & Gamble, where he was instrumental in the digital turnaround that led to P&G being named to AdAge’s Digital A-List. Dave was named to the iMedia 25 Class of Digital Innovators, by Cincinnati Business Courier as the CMO of the Year in the inaugural C-Suite Awards, and as a 40 Under 40 by both AdAge and the P&G Alumni Network. Dave is a frequent keynote on digital innovation and disruption, including appearances at SXSW, TEDx, Back End of Innovation, NRFtech, Brand Innovators, AdTech NYC, and the iMedia Summit. He is the co-founder of The Brandery – one of the top 10 startup accelerators in the country. Dave is also a Managing Partner in the seed fund Vine St Ventures, and an advisor to Bullpen Capital, Glasswing Ventures, and Hyde Park Venture Partners.

Kelly Land

Nearly twenty years as both an investor and advisor to numerous companies throughout the U.S. and international markets. His passion is working with unique, promising seed stage and early stage technology companies. He has experience in a number of industries including software, e-commerce, medical device, and manufacturing, having participated in over fifty transactions. With a focus on blockchain and open science, Mr. Land believes in being a first mover in breakthrough technologies and businesses. He has a Bachelor’s Degree in Mechanical Engineering from Rose Hulman Institute of Technology.

Martin Dueñas, MPA

Martin is currently is the Director of the Health Research Management Practice (HRMP) at Leidos (previously SAIC) – a fortune 500 company that supports government and non-government organizations in National Security, Engineering and Health . He works at the center of the life science ecosystem including government and private funding organizations, research academic centers, biotechs, and pharmaceuticals.  He is the founder of ONPAR - Online Partnership to Accelerate Research - a Global Public–Private Partnership that was launched with National Institute of Health and it now expands globally to include over 40 biomedical research funding organizations.  OnPAR seeks to advance research by funding highly scored unfunded research applications globally.  In addition, he serves as an advisor to several biotech companies and private biomedical foundations.  Mr. Dueñas experience includes research/faculty and executive positions at Columbia Medical Center, Weill Cornell Medical Center, Memorial-Sloan Kettering Cancer Center, Hospital for Special Surgery, New York University Medical Center, and the New York Academy of Medicine.

Dr. Roland Everett Langford

He has more than 40 years experience in environmental protection, occupational safety and health, and radiation protection. He holds Ph.D. degrees in Physical Chemistry from the University of Georgia and in Radiation Health Physics from the University of North Carolina at Chapel Hill, as well as a Masters degree in thermodynamics from the University of Georgia. In addition to academic degrees, he is a Certified Industrial Hygienist, a Certified Safety Professional, a licensed Professional Engineer in the State of Texas, a Certified Professional Environmental Auditor, a Certified Process Safety Auditor, a Fellow of the American Institute of Chemists, a Diplomat of the American Academy of Sanitarians, a Registered Hazardous Materials Professional, a Board Certified Environmental Scientist, and a registered Sanitarian. Dr. Langford is the author or co-author of three books (on Hazardous Materials Incidents, Workplace Drug Abuse, and Weapons of Mass Destruction). He served for twenty years in the U.S. Army Medical Department, retiring in the rank of Lieutenant Colonel, following command of the Army Research Detachment for Toxicology of the Walter Reed Army Institute of Research. He served with NATO in Bosnia and Croatia, receiving both the NATO Yugoslavia Medal and the Armed Forces Expeditionary Medal. He was awarded the Legion of Merit among other decorations. He worked in industry with the Huntsman Petrochemical Corporation, then as a Department of the Army civilian. He lived and worked in Korea and the Peoples Republic of China. Prior to military career, he was a college professor of chemistry and geology.

Li Guo, Ph.D

Li is the Scientific Community Manager at Open Therapeutics since 2016. She worked with technology team to develop the prototype of Therapoid platform for scientific collaboration. Li was the Director of Cellular Engineering at Microbial Robotics in 2014~2015. She was the principal investigator for the National Science Foundation's Small Business Innovation Research (SBIR) award. She worked with researchers (from US, Spain, India, etc.) on the synthetic biology-based product development and company's acquisition of intellectual properties. Li was research fellow of the Neuro-Oncology at Cincinnati Children's hospital Medical Center in 2007~2013. She conducted several research projects and published papers (at Journal of Neuroscience, Journal of Cell biology, Glia, etc.) as first author. She was also the recipient of the award from Natural Science Foundation of China. Li had her Ph.D in Neuroscience at the Chinese Academy of Sciences (CAS) at 2006 and her B.S at Xiamen University in 2001. Li lives in Cincinnati, US with her family, she travels to China a few times every year and works with nonprofit organizations.

Mr. Austin Kimm

COO and Co-Founder of Crypterium, the most successful blockchain-based ICO ever as measured by the number of token buyers. Crypterium, the world’s first mobile cryptocurrency bank, will enable everybody to transact with cryptocurrency in real world situations from the simplicity of their mobile phones. Austin in currently rolling out Crypterium on a global level, building the Crypterium infrastructure and opening offices in London, Singapore, USA and Moscow. Austin has advised on a number of successful ICO’s including STORIQA, which sold over $30m in token sales at the start of 2018.  Austin is an experienced results proven financial services CEO with long history of building successful insurance companies in both developing (Russia, Ukraine, Czech Republic) and developed (Australia, UK) insurance markets. Most recently (2006 to 2012) Austin built from the ground-up one of Russia’s most successful Insurance Companies, Renaissance Life & Pensions, having previously served in a number of country CEO or C-suit positions for Aviva, including Director of Strategy for Aviva’s International operations operating out of London. Since 2013 Austin has been focused on developing ground breaking Fintech start-ups, including CEO roles at Workle, Russia’s largest on-line employer that enables everybody to become their own self employed salesperson and Dynamic Re, where Austin is a co-founder of a unique life assurance distribution company offering life savings plans via retailer loyalty programs.

Peter McCrea

President and a Director of the Cavendish Impact Foundation, a donor advised Impact Investment platform. He began his career in his native California as a film editor, writer and cinematographer. He was a founding member of the American Cinema Awards Foundation, benefitting the Motion Picture and Television Fund. Subsequently, Peter was a partner at Americana Land Company, designing environmentally sustainable land developments. After moving to the East Coast in 1995, he served as Director of Development at LHO Group for Leif H. Olsen, former Chief Economist of Citibank, and since 2009 has been an acquisitions advisor for Hinduja Group, a multinational corporation. Before joining the Cavendish Impact Foundation, Peter was Vice President of Development at American Endowment Foundation with over 4,700 donor advised fund clients in all 50 states, and he was a Business Development Advisor at Foundation Source with 1,500 foundations and $9 billion in assets. Peter was also a member of the Board of Directors of the Morgan Stanley Global Impact Funding Trust, and served as Chairman of the Livelihoods Council at Save the Children. Since 2001, Peter has been a Trustee of the Lemmon Foundation, a conservation foundation.

Ed McKinzie

Principal Research Associate supporting the Sensors and Intelligent Systems and the Sensors and Electromagnetic Applications Laboratories at Georgia Tech Research Institute (GTRI). He has extensive experience in military operations, project management, developing advanced concepts, tests, and tactics, techniques, & procedures, and with creating a vision/plan to develop ground-breaking capabilities. Ed served over 28 years in the United States Air Force as an Air Battle Manager accumulating over 4,500 flying hours in command & control and surveillance aircraft (E-3 AWACS/E-8 JSTARS) and served in over 50 deployments/contingency operations. He had the pleasure of leading airmen as the Commander of an Air Force Squadron (965th AWACS) and as the Wing Commander for the 505th Air Control Wing improving the USAF warfighting capability through command and control testing, tactics development, and training. Mr. McKinzie held key positions on the Joint Staff, United States Central Command, International Security Assistance Force, United States Africa Command, NORAD and United States Northern Command.

Louis Page

Louise Page joined PLOS in 2015. In her role as Chief Innovation Officer, she is responsible for actualizing PLOS’ strategy in Open Science to maximize the influence, impact, and dissemination of research globally leveraging emerging technology and new opportunities to open up scientific communication. Prior to PLOS, Louise was Vice President, Publisher Relations and Business Development at HighWire Press where she successfully managed teams responsible for publisher account management, business development, and strategic planning for the company’s global publisher network. Previously, Louise held technology and editorial leadership positions at John Wiley & Sons where she steered the organization into the digital age with its first online journal and Wiley InterScience. She has also held editorial positions at Oxford University Press. Louise currently serves on the Board of the Open Access Scholarly Publishers Association and is on the Free the Science Advisory Board of the Electrochemical Society.

Raymond Scalettar, MD, DSc, FACP

A practicing physician specializing in Rheumatology and Internal medicine in Washington DC. He is Clinical Professor Emeritus of Medicine at the George Washington University Medical Center, Master of the American College of Rheumatology, a Fellow of the American College of Physicians and a distinguished Fellow of the American Psychiatric Association. He was instrumental in the development of the world class National Rehabilitation Hospital and was its first Medical Staff President. Affordable, quality medical care for patients has been a foremost objective throughout his professional career. He was elected to the Board of Trustees of the American Medical Association and ultimately its Chair; he was a Commissioner and later a Consultant to the Joint Commission on Accreditation of Healthcare Organizations; he helped form and was an executive in a physician owned professional liability organization, NCRIC. He is a Medical Expert Consultant to the Social Security Administration and a Consultant to the American College of Rheumatology

Rosemarie Truman

Founder and CEO of the Center for Advancing Innovation (CAI), a 501c3 non-profit which has been coined “Tinder for Startups” and “Shark Tank on Steroids.” CAI's mission is to identify breakthrough inventions and maximize their commercial potential. With over 25 years of experience in entrepreneurship, executive leadership, and philanthropy, Rosemarie’s specialty is venture investment strategy, having led growth strategies for 50 of the global Fortune 100 companies in over 15 countries. The strategies that Rosemarie led have resulted in $300+ billion in “net new” top line yearly revenue and 190+ new products on the market.

As CAI’s leader, Rosemarie has pioneered a first-of-a-kind, award-winning, disruptive innovation platform. Orchestrating 6 innovative challenge-accelerator models CAI has been the catalyst for the launch of 100+ companies, 5000+ entrepreneurs, and 80+ partnerships across federal labs, universities and hospitals. CAI has created new business model architectures for obtaining inventions, now an established paradigm for commercializing federally-funded inventions.

Prior to launching her own firm, Rosemarie spearheaded IBM’s Innovation strategy practice globally and was awarded IBM’s most laudable honor, the Golden Circle Award. In addition, she has also held leadership roles at Booz Allen Hamilton, Oracle, PRTM, and Marsh & McLennan, where she served as VP of global strategy. Rosemarie began her career at Goldman Sachs.

Rosemarie Truman is an entrepreneur, growth strategist, distinguished corporate executive, angel investor and prolific startup catalyst. Rosemarie’s specialty is growth and investment strategy, having led growth strategies for 50 of the global Fortune 100 companies in over 15 countries. The strategies that Rosemarie led have resulted in $300+ billion in “net new” top line yearly revenue and 190+ new products on the market. In her spare time, Rosemarie also writes for Forbes and sits on company boards.

Rosemarie has led the due diligence of over 500,000 pieces of intellectual property and commercialization of over 2000 resulting in more than 200 startups and $210 billion.  In addition, Rosemarie has led growth strategies and transformations for 50 of the top 100 technology transfer/commercialization organizations in the world.

Jeffrey S. Wallace

Professor of Personal Finance at Snow College and an active Real Estate, Private Business, and Cryptocurrency Investor. He completed his graduate work at Utah State University with an emphasis in Family-Owned Businesses (Determinants of Business Success and Profitability) and possesses an active Utah real estate license. He is an expert negotiator, business consultant, and a highly rated professor of Business and Social & Behavior Sciences. Jeff has published many articles related to business and personal finance and is an avid blockchain technology advocate.